Sarah M. Bagley MD

Associate Professor, General Internal Medicine

Associate Professor, Adolescent Medicine

801 Massachusetts Ave | (617) 414-7399
sarah.bagley@bmc.org
sbagley@bu.edu

Sections

General Internal Medicine

Centers

Clinical Addiction Research and Education Unit

Biography

Sarah Bagley is an Associate Professor of Medicine and Pediatrics at the Chobanian & Avedisian School of Medicine and is board certified in Pediatrics, Internal Medicine, and Addiction Medicine. She is the founder of the CATALYST at Boston Medical Center, a clinical program providing integrated substance use care and primary care for youth where she sees patients. Her passion is to ensure that all youth who use substances have access to high quality, equitable care to promote their health. Her research focus is on the engagement of young adults who use drugs and their families in care to minimize risk for overdose and the complications of drug use. She has funding from the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and PCORI to conduct research about engagement in treatment and overdose prevention of young adults after nonfatal opioid overdose and reducing stimulant related overdose.

Websites

BU Profile

BUMC Profile

Education

Medicine-Internal, MD, Georgetown University School of Medicine

Public Health - Epidemiology, MSc, Boston University School of Public Health

Classics, BA, Brown University

Publications

Published on 9/10/2025

Walley AY, Wang J, To C, Duska M, Murray S, Wiggins M, Rolles A, Yan S, Kosakowski S, Bagley SM, Xuan Z, Hyde J, Formica SW. Post-overdose outreach programs in Massachusetts before and after the onset of the COVID-19 pandemic. J Subst Use Addict Treat. 2025 Sep 10; 179:209799. PMID: 40939693.

PubMed

Published on 9/1/2025

Cano M, Hernandez N, Mendoza NS, Bagley SM. Fewer Than 1 In 3 Adolescents With Past-Year Opioid Use Disorder Received Substance Use Treatment, 2022-23. Health Aff (Millwood). 2025 Sep; 44(9):1060-1069. PMID: 40893078.

PubMed

Published on 7/31/2025

Harris MTH, Hall M, Ellison S, Holloway J, Bridden C, Bagley SM, Bullard M, Chassler D, Chatterjee A, Dasgupta A, Drainoni ML, Gruss DE, Jadovich E, Katz R, Mayotte C, Neufeld JL, Oga E, Glasgow L. Tailored strategies to reduce opioid overdose deaths for pregnant and postpartum women: Examples and lessons learned from the HEALing Communities Study. J Subst Use Addict Treat. 2025 Oct; 177:209766. PMID: 40752834.

PubMed

Published on 7/30/2025

Calihan JB, Ventura AS, Wang J, Puppala R, Wiggins M, Renehan C, Garrity B, Bagley SM. Engaging Affected Family Members in Substance Use Disorder Care: Knowledge, Attitudes, and Behaviors of Addiction Care Teams. Subst Use Addctn J. 2025 Jul 30; 29767342251355135. PMID: 40737121.

PubMed

Published on 7/9/2025

Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785. PMID: 40684522.

PubMed

Published on 6/20/2025

Calihan JB, Liu G, Raftery K, Goullaud L, LaFleur J, Walt G, Chaiyachati BH, Bagley SM, Gray JR, Schiff DM. Perspectives of Mothers With Substance Use Disorder on Naloxone Education: "I'm Ready to Have Those Conversations About Who I Was, Because That's Not Who I Am". J Addict Med. 2025 Jun 20. PMID: 40539630.

PubMed

Published on 5/9/2025

Renehan CM, Wiggins M, Puppala R, Chatterjee A, Obando A, Coleman KR, Raj A, Schmill DM, Flynn D, Bagley SM. A Scoping Review of Youth Overdose Prevention Interventions. J Addict Med. 2025 May 09. PMID: 40344021.

PubMed

Published on 4/25/2025

Chavez LJ, Yu O, Wartko PD, Braciszewski JM, Glass JE, Horigian VE, Arnsten JH, Murphy MT, Stotts AL, Bagley SM, Lapham GT, Samet JH. Opioid use disorder medications among youth in primary care: Subgroup analysis of the PROUD trial. Pediatr Open Sci. 2025; 1(2). PMID: 40718732.

PubMed

Published on 4/11/2025

Gilbert L, Chahine R, Chandler R, Feaster DJ, Kim E, Aldridge A, Bagley S, Balvanz P, Fernandez S, Rock P, Vickers-Smith RA, Villani J, Battaglia T, Brown J, Bush H, Chase RP, Collins T, D'Costa L, Damato-MacPherson C, David JL, Defiore-Hyrmer J, Freeman PR, Glasgow L, Hammerslag LR, Hotchkiss J, Hunt T, Hussain S, Kamanu V, Knott C, Knudsen HK, LaRochelle M, Laudate A, Lyons M, McMullan J, Nakayima J, Schackman BR, Slavova S, Tan S, Vandergrift N, Walters ST, Westgate PM, Wu E, Young AM, Zarkin GA, Freisthler B, Oga E, Samet JH, Walsh SL, Winhusen J, Jackson R, El-Bassel N. The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial. Int J Drug Policy. 2025 Jun; 140:104798. PMID: 40220509.

PubMed

Published on 2/21/2025

Lee H, Thulien M, Eekhoudt CR, Friesen D, Manson D, Bagley S, Hadland S, Fast D. Building social support into mental health and substance use treatment trajectories: Insights from a longitudinal qualitative and ethnographic study with young people experiencing unstable housing and homelessness. Child Youth Serv. 2025 Feb 21. PMID: 40857527.

PubMed

View full list of 94 publications.